Delivery Order SPE2DB24D6041-SPE2DB25FKCMA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,767.72 to AmerisourceBergen Drug Corp for Estradiol 0.06% 1.25G Gel Pump (37.5GM) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estradiol 0.06% 1.25g gel pump, 37.5g in Conshohocken, Pennsylvania. The award has a ceiling value of $1,723.82 and a completion date of June 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $1,503.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Estradiol 0.06% 1.25G gel pump in 50GM quantities. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of August 19, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major supplier of pharmaceutical products...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Estradiol 0.06% 1.25g gel pump, 37.5g, with a total ceiling value of $1,288.29. The contract type is firm fixed price, and the ultimate completion date is May 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides...
- The Defense Logistics Agency awarded a $69,350 delivery order to Amerisourcebergen Drug Corporation for the supply of 0.1% estradiol gel in 30-count packages. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania over a three-day period concluding on July 3, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with an existing DLA-wide contract vehicle. Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram quantities. This firm fixed-price delivery order, valued at $1,255.56, represents a non-competitive set-aside transaction and is scheduled for completion by August 26, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on July 22, 2025, with a ceiling value of $1,150.32 and an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $2,247 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561586311 ESTRADIOL 0.1% (1 MG) GEL PKTGM to be delivered from the contractor's location in Conshohocken, Pennsylvania to an unspecified destination. Performance is required from July 24-25, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports...
- The Defense Logistics Agency awarded a $2,628.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Estradiol 10 MCG Vaginal Insert (8 count) on August 7, 2025, with completion scheduled for August 8, 2025. This delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Estrace 0.01% Cream in a 42.5-gram quantity. This firm fixed-price delivery order, valued at $5,201.20, represents a non-competitive set-aside procurement and is scheduled for completion by July 23, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCMADelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,221.14 on August 25, 2025, for the supply of Estradiol 0.06% 1.25G Gel Pump in 37.5GM quantity. The contract is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order represents a task order against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive pharmaceutical supply vehicle enabling the company to deliver a broad portfolio of medications, vaccines, medical supplies, and specialty pharmaceuticals to support military healthcare systems globally. AmerisourceBergen's federal contract portfolio demonstrates extensive experience supplying hormone treatments and other specialized pharmaceuticals to support Defense Health Agency and federal healthcare customers across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/25/25 |